Issue 43, 2022

Viscosity-sensitive NIR probe for in vivo imaging of early-stage hepatic fibrosis

Abstract

Herein, a viscosity-sensitive and hepatic-targeted NIR fluorescent probe has been developed for early diagnosis of hepatic fibrosis. Importantly, we observed increased liver viscosity upon CCl4-induced hepatotoxicity and decreased liver viscosity after metformin treatment, which confirmed its high clinical application prospects.

Graphical abstract: Viscosity-sensitive NIR probe for in vivo imaging of early-stage hepatic fibrosis

Supplementary files

Article information

Article type
Communication
Submitted
16 Aug 2022
Accepted
10 Oct 2022
First published
11 Oct 2022

J. Mater. Chem. B, 2022,10, 8852-8855

Viscosity-sensitive NIR probe for in vivo imaging of early-stage hepatic fibrosis

W. Zhang, Y. Lv, F. Huo, Y. Zhang and C. Yin, J. Mater. Chem. B, 2022, 10, 8852 DOI: 10.1039/D2TB01746F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements